NCT07680803 Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia Status RECRUITING Phase PHASE2
NCT07506863 A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) Status RECRUITING Phase PHASE3
NCT07055503 Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients Status ENROLLING_BY_INVITATION Phase N/A
NCT06363760 A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301 Status ENROLLING_BY_INVITATION Phase N/A
NCT06219239 Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients Status RECRUITING Phase NA
NCT06146478 Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients Status COMPLETED Phase PHASE3
NCT05991336 Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy Status RECRUITING Phase N/A
NCT05860595 Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia. Status ACTIVE_NOT_RECRUITING Phase NA
NCT04770779 A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02633943 Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy Status ACTIVE_NOT_RECRUITING Phase N/A